BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38539499)

  • 21. [Significance of PAX5 deletion in childhood B-lineage acute lymphoblastic leukemia without reproducible chromosomal abnormalities].
    Liu XM; Zhang L; Ruan M; Liu TF; Zhang JY; Liu F; Qi BQ; Chen XJ; Wang SC; Yang WY; Guo Y; Zou Y; Chen YM; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2016 Apr; 18(4):287-91. PubMed ID: 27097569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.
    Ou Z; Sherer M; Casey J; Bakos HA; Vitullo K; Hu J; Friehling E; Gollin SM; Surti U; Yatsenko SA
    Cytogenet Genome Res; 2016; 150(3-4):242-252. PubMed ID: 28214896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mutational spectrum and its prognostic significance in childhood acute lymphoblastic leukemia based on next-generation sequencing technology].
    Zheng YZ; Zheng H; Chen ZS; Hua XL; Le SH; Li J; Hu JD
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jan; 43(1):19-25. PubMed ID: 35231988
    [No Abstract]   [Full Text] [Related]  

  • 24. Prognostic significance of copy number alterations detected by multi-link probe amplification of multiple genes in adult acute lymphoblastic leukemia.
    Fang Q; Yuan T; Li Y; Feng J; Gong X; Li Q; Zhao X; Liu K; Tang K; Tian Z; Zhang Q; Wang Y; Liu B; Wang M; Ru K; Wang J; Mi Y
    Oncol Lett; 2018 Apr; 15(4):5359-5367. PubMed ID: 29552179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001.
    Tran TH; Langlois S; Meloche C; Caron M; Saint-Onge P; Rouette A; Bataille AR; Jimenez-Cortes C; Sontag T; Bittencourt H; Laverdière C; Lavallée VP; Leclerc JM; Cole PD; Gennarini LM; Kahn JM; Kelly KM; Michon B; Santiago R; Stevenson KE; Welch JJG; Schroeder KM; Koch V; Cellot S; Silverman LB; Sinnett D
    Blood Adv; 2022 Feb; 6(4):1329-1341. PubMed ID: 34933343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PAX5-KIAA1549L: a novel fusion gene in a case of pediatric B-cell precursor acute lymphoblastic leukemia.
    Anderl S; König M; Attarbaschi A; Strehl S
    Mol Cytogenet; 2015; 8():48. PubMed ID: 26157485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAX5-AUTS2: a recurrent fusion gene in childhood B-cell precursor acute lymphoblastic leukemia.
    Denk D; Nebral K; Bradtke J; Pass G; Möricke A; Attarbaschi A; Strehl S
    Leuk Res; 2012 Aug; 36(8):e178-81. PubMed ID: 22578776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genes commonly deleted in childhood B-cell precursor acute lymphoblastic leukemia: association with cytogenetics and clinical features.
    Schwab CJ; Chilton L; Morrison H; Jones L; Al-Shehhi H; Erhorn A; Russell LJ; Moorman AV; Harrison CJ
    Haematologica; 2013 Jul; 98(7):1081-8. PubMed ID: 23508010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk assessment of
    Khalid A; Aslam S; Ahmed M; Hasnain S; Aslam A
    PeerJ; 2019; 7():e7195. PubMed ID: 31565544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia.
    Krentz S; Hof J; Mendioroz A; Vaggopoulou R; Dörge P; Lottaz C; Engelmann JC; Groeneveld TW; Körner G; Seeger K; Hagemeier C; Henze G; Eckert C; von Stackelberg A; Kirschner-Schwabe R
    Leukemia; 2013 Feb; 27(2):295-304. PubMed ID: 22699455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common clonal origin of an acute B-lymphoblastic leukemia and a Langerhans' cell sarcoma: evidence for hematopoietic plasticity.
    Ratei R; Hummel M; Anagnostopoulos I; Jähne D; Arnold R; Dörken B; Mathas S; Benter T; Dudeck O; Ludwig WD; Stein H
    Haematologica; 2010 Sep; 95(9):1461-6. PubMed ID: 20421277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
    Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
    Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Cario G; Rhein P; Mitlöhner R; Zimmermann M; Bandapalli OR; Romey R; Moericke A; Ludwig WD; Ratei R; Muckenthaler MU; Kulozik AE; Schrappe M; Stanulla M; Karawajew L
    Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.
    Biondi A; Valsecchi MG; Seriu T; D'Aniello E; Willemse MJ; Fasching K; Pannunzio A; Gadner H; Schrappe M; Kamps WA; Bartram CR; van Dongen JJ; Panzer-Grümayer ER
    Leukemia; 2000 Nov; 14(11):1939-43. PubMed ID: 11069029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MLPA and DNA index improve the molecular diagnosis of childhood B-cell acute lymphoblastic leukemia.
    Yu CH; Lin TK; Jou ST; Lin CY; Lin KH; Lu MY; Chen SH; Cheng CN; Wu KH; Wang SC; Chang HH; Li MJ; Ni YL; Su YN; Lin DT; Chen HY; Harrison CJ; Hung CC; Lin SW; Yang YL
    Sci Rep; 2020 Jul; 10(1):11501. PubMed ID: 32661308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX5 alterations in an infant case of KMT2A-rearranged leukemia with lineage switch.
    Nakajima K; Kubota H; Kato I; Isobe K; Ueno H; Kozuki K; Tanaka K; Kawabata N; Mikami T; Tamefusa K; Nishiuchi R; Saida S; Umeda K; Hiramatsu H; Adachi S; Takita J
    Cancer Sci; 2022 Jul; 113(7):2472-2476. PubMed ID: 35467057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAX5 fusion genes in acute lymphoblastic leukemia: A literature review.
    Fouad FM; Eid JI
    Medicine (Baltimore); 2023 May; 102(20):e33836. PubMed ID: 37335685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
    Tomoyasu C; Imamura T; Tomii T; Yano M; Asai D; Goto H; Shimada A; Sanada M; Iwamoto S; Takita J; Minegishi M; Inukai T; Sugita K; Hosoi H
    Int J Hematol; 2018 Sep; 108(3):312-318. PubMed ID: 29786757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.